A longitudinal assessment of acute cough.

RATIONALE: Cough can be assessed with visual analog scales (VAS), health status measures, and 24-hour cough frequency monitors (CF(24)). Evidence for their measurement properties in acute cough caused by upper respiratory tract infection (URTI) and longitudinal data is limited. OBJECTIVES: To asses...

Description complète

Détails bibliographiques
Auteurs principaux: Lee, K, Matos, S, Evans, D, White, P, Pavord, I, Birring, S
Format: Journal article
Langue:English
Publié: 2013
_version_ 1826301784353669120
author Lee, K
Matos, S
Evans, D
White, P
Pavord, I
Birring, S
author_facet Lee, K
Matos, S
Evans, D
White, P
Pavord, I
Birring, S
author_sort Lee, K
collection OXFORD
description RATIONALE: Cough can be assessed with visual analog scales (VAS), health status measures, and 24-hour cough frequency monitors (CF(24)). Evidence for their measurement properties in acute cough caused by upper respiratory tract infection (URTI) and longitudinal data is limited. OBJECTIVES: To assess cough longitudinally in URTI with subjective and objective outcome measures and determine sample size for future studies. METHODS: Thirty-three previously healthy subjects with URTI completed cough VAS, Leicester Cough Questionnaire (LCQ-acute), and CF(24) monitoring (Leicester Cough Monitor) on three occasions, 4 days apart. Changes in subjects' condition were assessed with a global rating of change questionnaire. The potential for baseline first-hour cough frequency (CF(1)), VAS, and LCQ to identify low CF(24) was assessed. MEASUREMENTS AND MAIN RESULTS: Mean ± SD duration of cough at visit 1 was 4.1 ± 2.5 days. Geometric mean ± log SD baseline CF(24) and median (interquartile range) cough bouts were high (14.9 ± 0.4 coughs/h and 85 [39-195] bouts/24 h). Health status was severely impaired. There was a significant reduction in CF(24) and VAS, and improvement in LCQ, from visits 1-3. At visit 3, CF(24) remained above normal limits in 52% of subjects. The smallest changes in CF(24), LCQ, and VAS that subjects perceived important were 54%, 2- and 17-mm change from baseline, respectively. The sample sizes required for parallel group studies to detect these changes are 27, 51, and 25 subjects per group, respectively. CF(1) (<20.5 coughs/h) was predictive of low CF(24). CONCLUSIONS: CF(24), VAS, and LCQ are responsive outcome tools for the assessment of acute cough. The smallest change in cough frequency perceived important by subjects is 54%. The sample sizes required for future studies are modest and achievable.
first_indexed 2024-03-07T05:37:36Z
format Journal article
id oxford-uuid:e47239c9-c90f-4acd-97d5-52cfe8b192fc
institution University of Oxford
language English
last_indexed 2024-03-07T05:37:36Z
publishDate 2013
record_format dspace
spelling oxford-uuid:e47239c9-c90f-4acd-97d5-52cfe8b192fc2022-03-27T10:16:43ZA longitudinal assessment of acute cough.Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:e47239c9-c90f-4acd-97d5-52cfe8b192fcEnglishSymplectic Elements at Oxford2013Lee, KMatos, SEvans, DWhite, PPavord, IBirring, S RATIONALE: Cough can be assessed with visual analog scales (VAS), health status measures, and 24-hour cough frequency monitors (CF(24)). Evidence for their measurement properties in acute cough caused by upper respiratory tract infection (URTI) and longitudinal data is limited. OBJECTIVES: To assess cough longitudinally in URTI with subjective and objective outcome measures and determine sample size for future studies. METHODS: Thirty-three previously healthy subjects with URTI completed cough VAS, Leicester Cough Questionnaire (LCQ-acute), and CF(24) monitoring (Leicester Cough Monitor) on three occasions, 4 days apart. Changes in subjects' condition were assessed with a global rating of change questionnaire. The potential for baseline first-hour cough frequency (CF(1)), VAS, and LCQ to identify low CF(24) was assessed. MEASUREMENTS AND MAIN RESULTS: Mean ± SD duration of cough at visit 1 was 4.1 ± 2.5 days. Geometric mean ± log SD baseline CF(24) and median (interquartile range) cough bouts were high (14.9 ± 0.4 coughs/h and 85 [39-195] bouts/24 h). Health status was severely impaired. There was a significant reduction in CF(24) and VAS, and improvement in LCQ, from visits 1-3. At visit 3, CF(24) remained above normal limits in 52% of subjects. The smallest changes in CF(24), LCQ, and VAS that subjects perceived important were 54%, 2- and 17-mm change from baseline, respectively. The sample sizes required for parallel group studies to detect these changes are 27, 51, and 25 subjects per group, respectively. CF(1) (<20.5 coughs/h) was predictive of low CF(24). CONCLUSIONS: CF(24), VAS, and LCQ are responsive outcome tools for the assessment of acute cough. The smallest change in cough frequency perceived important by subjects is 54%. The sample sizes required for future studies are modest and achievable.
spellingShingle Lee, K
Matos, S
Evans, D
White, P
Pavord, I
Birring, S
A longitudinal assessment of acute cough.
title A longitudinal assessment of acute cough.
title_full A longitudinal assessment of acute cough.
title_fullStr A longitudinal assessment of acute cough.
title_full_unstemmed A longitudinal assessment of acute cough.
title_short A longitudinal assessment of acute cough.
title_sort longitudinal assessment of acute cough
work_keys_str_mv AT leek alongitudinalassessmentofacutecough
AT matoss alongitudinalassessmentofacutecough
AT evansd alongitudinalassessmentofacutecough
AT whitep alongitudinalassessmentofacutecough
AT pavordi alongitudinalassessmentofacutecough
AT birrings alongitudinalassessmentofacutecough
AT leek longitudinalassessmentofacutecough
AT matoss longitudinalassessmentofacutecough
AT evansd longitudinalassessmentofacutecough
AT whitep longitudinalassessmentofacutecough
AT pavordi longitudinalassessmentofacutecough
AT birrings longitudinalassessmentofacutecough